Pharmaceuticals

Geriatric Population Surge Fuels Pain Management Drugs Market Is Supporting Development Across The Pain Management Drugs Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Size Is Forecasted For The Pain Management Drugs Market By 2030 Based On Its 2026 Value?

The market size for pain management drugs has experienced considerable growth in recent years. Projections indicate it will expand from $84.79 billion in 2025 to $89.3 billion in 2026, driven by a compound annual growth rate (CAGR) of 5.3%. This historical growth is attributable to factors like the increasing prevalence of chronic pain conditions, an expanding geriatric population, heightened awareness regarding pain management, the broadening of hospital and retail pharmacy networks, and breakthroughs in analgesic drug formulations.

The pain management drugs market size is anticipated to experience substantial expansion in the upcoming years. It will grow to $108.86 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. This projected expansion is due to several factors, such as the increasing use of biologics for pain management, the greater incorporation of digital health solutions, a rising need for minimally invasive procedures, the spread of home healthcare services, and breakthroughs in combination therapies. Key developments expected during this period encompass tailored pain management treatments, telemedicine alongside remote pain monitoring, new formulations for analgesic drugs, less invasive methods for pain relief, and strategies involving combination therapy.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9846&type=smp

What Important Drivers Are Powering The Pain Management Drugs Market Growth?

The expanding geriatric population, which encompasses individuals 65 years and older, is set to propel the growth of the pain management drugs market. These medications are frequently prescribed to older patients to alleviate discomfort from conditions such as arthritis, cancer, and neurological disorders, all of which are more common later in life; hence, the rise in the geriatric population is expected to boost the pain management drugs market. Illustratively, in November 2025, the Organisation for Economic Co-operation and Development (OECD), a France-based intergovernmental economic organization, reported that the share of the population aged 65 and over has, on average, doubled across OECD countries over the past 50 years, increasing from 18.5% in 2023. This demonstrates that the increasing geriatric population is a significant factor driving the growth of the pain management drugs market.

Which Segment Groups Define The Pain Management Drugs Market Landscape?

The pain management drugs market covered in this report is segmented –

1) By Drug Class: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Anesthetics, Anticonvulsants, Anti-Migraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics

2) By Indication: Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Muscle Sprain Or Strain, Bone Fracture, Other Indications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Aspirin, Diclofenac, Ketorolac

2) By Anesthetics: Local Anesthetics, General Anesthetics

3) By Anticonvulsants: Gabapentin, Pregabalin, Carbamazepine, Topiramate

4) By Anti-Migraine Agents: Triptans, Ergot Alkaloids, CGRP Inhibitors

5) By Antidepressants: Tricyclic Antidepressants, SNRIs

6) By Opioids: Morphine, Oxycodone, Hydrocodone, Fentanyl

7) By Nonnarcotic Analgesics: Acetaminophen, Aspirin, Other Analgesics

What Trends Are Influencing The Future Of The Pain Management Drugs Market?

Major companies operating in the pain management drugs market are focused on developing new medications and obtaining FDA approval to cater to patients suffering from acute or chronic pain. FDA approval represents the regulatory endorsement provided by the U.S. Food and Drug Administration, indicating that a medical product meets the required safety and effectiveness standards for sale in the United States. For example, in October 2023, Hyloris Pharmaceuticals, a pharmaceutical company based in Belgium, secured U.S. FDA approval for Maxigesic IV. Maxigesic IV is notable as the first non-opioid painkiller to receive FDA approval in over 20 years. This product is a non-opioid intravenous painkiller that incorporates both paracetamol and ibuprofen, thereby offering a dual-action mechanism for pain relief. The approval of Maxigesic IV signifies a considerable advancement in the pain management drugs market, providing a new non-opioid treatment option for post-operative pain management.

Which Firms Are Competing In The Pain Management Drugs Market?

Major companies operating in the pain management drugs market are Novartis AG, Eli Lilly And Company, Abbott Laboratories, Endo International plc, Pfizer Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., GlaxoSmithKline plc, AbbVie Inc., Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Bausch Health Companies Inc., Sanofi, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim, Mallinckrodt Pharmaceuticals, Daiichi Sankyo Company Limited, Grünenthal GmbH, Mundipharma International Limited, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Zydus Cadila, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd.

Access The Complete Pain Management Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Which Area Represents The Largest Portion Of The Pain Management Drugs Market?

North America was the largest region in the pain management drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the pain management drug market report during the forecast period. The regions covered in the pain management drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pain Management Drugs Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=9846&type=smp

Browse Through More Reports Similar to the Global Pain Management Drugs Market 2026, By The Business Research Company

Pain Management Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Analgesics Market Report 2026

https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report

Muscle Pain Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/muscle-pain-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795